An attenuated mutant of avian pathogenic Escherichia coli serovar O78: A possible live vaccine strain for prevention of avian colibacillosis

Microbiology and Immunology

Volumn 56, Issue 9, 2012, Pages 605-612

  Nagano, Tetsuji ^a   Kitahara, Rie ^a   Nagai, Shinya ^a  

^a NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

Author keywords

Colibacillosis; Deletion mutant; Live vaccine; Poultry

Indexed keywords

ESCHERICHIA COLI VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN COLIBACILLOSIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EMBRYO; ESCHERICHIA COLI; IMMUNOREACTIVITY; INFECTION PREVENTION; LD 50; NONHUMAN; PROVOCATION TEST; RESPIRATORY TRACT MUCOSA; SEROTYPE; TREATMENT DURATION; VACCINE PRODUCTION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; CHICK EMBRYO; CHICKENS; CONGO RED; CYCLIC AMP RECEPTOR PROTEIN; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; GENE DELETION; GENES, BACTERIAL; LETHAL DOSE 50; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; POULTRY DISEASES; VACCINATION; VACCINES, ATTENUATED;

AVES; ESCHERICHIA COLI; GALLUS GALLUS; SPONDIAS PURPUREA;

EID: 84865562321     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00482.x     Document Type: Article

References (43)

1. Barnes H.J., Nolan L.K., Vaillancourt J.P. (2008) Colibacillosis. In: Saif Y.M., Fadly A.M., Glisson J.R., McDougald L.R., Nolan L.K., Swayne D.E., eds. Disease of poultry, 12th edn. Ames, Iowa, USA: Blackwell Publishing Professional, pp. 691-737.
2. Dho-Moulin M., Fairbrother J.M. (1999) Avian pathogenic Escherichia coli (APEC). Vet Res 30: 299-316.
3. Delicato E.R., de Brito B.G., Garziri L.C., Vidotto M.C. (2003) Virulence-associated genes in Escherichia coli isolates from poultry with colibacillosis. Vet Microbiol 94: 97-103.
4. Dheilly A., Bouder A., Le Devendec L., Hellard G., Kemph I. (2011) Clinical and microbial efficacy of antimicrobial treatments of experimental avian colibacillosis. Vet Microbiol 149: 422-9.
5. Dhillon A.S., Jack O.K. (1996) Two outbreaks of colibacillosis in commercial caged layers. Avian Dis 40: 742-6.
6. Goren E.W., De Jong A., Doornenbal P. (1982) Pharmacokinetical aspects of flumequine and therapeutic efficacy in Escherichia coli infection in poultry. Avian Pathol 11: 463-74.
7. Gregersen R.H., Christensen H., Ewers C., Bisgaard M. (2010) Impact of Escherichia coli vaccine on parent stock mortality, first week mortality of broilers and population diversity of E. coli in vaccinated flocks. Avian Pathol 39: 287-95.
8. Allan B.J., van den Hurk J.V., Potter A.A. (1993) Characterization of Escherichia coli isolated from cases of avian colibacillosis. Can J Vet Res 57: 146-51.
9. van Hoorebeke S., van Immerseel F., Berge A.C., Persoons D., Schulz J., Hartung J., Harisberger M., Regula G., Barco L., Ricci A., de Vylder J., Ducatelle R., Haesebrouck F., Dewulf J. (2011) Antimicrobial resistance of Escherichia coli and Enterococcus faecalis in housed laying-hen flocks in Europe. Epidemiol Infect 139: 1610-20.
10. Ozawa M., Baba K., Asai T. (2010) Molecular typing of avian pathogenic Escherichia coli O78 strains in Japan by using multilocus sequence typing and pulse-field gel electrophoresis. J Vet Med Sci 72: 1517-20.
11. Ozawa M., Harada K., Kojima A., Asai T., Sameshima T. (2008) Antimicrobial susceptibilities, serogroups and molecular characterization of avian pathogenic Escherichia coli isolates in Japan. Avian Dis 52: 392-7.
12. Papadopoulou C., Dimitriou D., Levidiotou S., Gessouli H., Panagiou A., Golegou S., Antoniades G. (1997) Bacterial strains isolated from eggs and their resistance to currently used antibiotics: is there a health hazard for consumers? Comp Immunol Microbiol Infect Dis 20: 35-40.
13. Deb J.R., Harry E.G. (1976) Laboratory trials with inactivated vaccines against Escherichia coli O78:K80 infection in fowls. Res Vet Sci 20: 131-8.
14. Deb J.R., Harry E.G. (1978) Laboratory trials with inactivated vaccines against Escherichia coli O2:K1 infection in fowls. Res Vet Sci 24: 308-13.
15. Panigrahy B., Gyimah J.E., Hall C.F., Williams J.D. (1984) Immunogenic potency of an oil-emulsified Escherichia coli bacterin. Avian Dis 28: 475-81.
16. Rosenberger J.K., Fries P.A., Cloud S.S. (1985) In vitro and in vivo characterization of avian Escherichia coli. III. Immunization. Avian Dis 29: 1108-1117.
17. Gyimah J.E., Panigrahy, B. (1985) Immunogenicity of an Escherichia coli (serotype O1) pili vaccine in chickens. Avian Dis 29: 1078-83.
18. Gyimah J. E., Panigrahy B., Williams J.D. (1986) Immunogenicity of an Escherichia coli multivalent pilus vaccine in chickens. Avian Dis 30: 687-9.
19. Bolin C.A., Jensen A.E. (1987) Passive immunization with antibodies against iron-regulated outer membrane proteins protects turkeys from Escherichia coli septicemia. Infect Immun 55: 1239-42.
20. Lynne A.M., Foley S.L., Nolan L.K. (2006) Immune response to recombinant Escherichia coli Iss protein in poultry. Avian Dis 50: 273-6.
21. Yaguchi, K., Ohgitani T., Noro T., Kaneshige T., Shimizu Y. (2009) Vaccination of chickens with liposomal inactivated avian pathogenic Escherichia coli (APEC) vaccine by eye drop or coarse spray administration. Avian Dis 53: 245-9.
22. Kwaga J.K., Allan B.J., van der Hurk J.V., Seida H., Potter A.A. (1994) A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infect Immun 62: 3766-72.
23. Peighambari S.M., Gyles C.L. (1998) Construction and characterization of avian E. coli cya crp mutants. Avian Dis 42: 698-710.
24. Peighambari S.M., Hunter D.B., Shewen P.E., Gyles C.L. (2002) Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers. Avian Dis 46: 287-97.
25. Kariyawasam S., Wilkie B.N., Gyles C.L. (2004) Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli. Avian Dis 48: 287-99.
26. Fan H.H., Kumar M., Marcello R., Woodward M.J. (2009) Avian E. coli vaccine for protection against colibacillosis. U. S. Patent 7, 575, 754. August 18, 2009.
27. Cossart P., Groisman E.A., Serre M.-C., Casadaban M.J., Gicquel-Sanzey B. (1986) Crp genes of Shigella flexneri, Salmonella typhimurium, and Escherichia coli. J Bacteriol 167: 639-46.
28. Gottesman S. (1984) Bacterial regulation: global regulatory networks. Annu Rev Genet 18: 415-41.
29. Sabourin, D., Beckwith J. (1975) Deletion of the Escherichia coli crp gene. J Bacteriol 122: 338-40.
30. Cao Y., Wen Z., Lu D. (1992) Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella Typhimurium. Infect Immun 60: 2823-7.
31. Roberts, M., Maskell D., Novotny P., Dougan G. (1990) Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect Immun 58: 732-9.
32. Forsman K., Sonden B., Goransson M., Uhlin B.T. (1992) Antirepression function in Escherichia coli for the cAMP-cAMP receptor protein transcriptional activator. Proc Natl Acad Sci 89: 9880-4.
33. Curtiss R. III, Kelly S.M. (1994) Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 62: 5519-27.
34. Kelly S.M., Bosecker B.A., Curtiss R. III. (1992) Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect Immun 60: 4881-90.
35. Tacket C.O., Hone D.M., Curtiss R. III, Kelly S.M., Losonsky G., Guers L., Harris A.M., Edelman R., Levine M.M. (1992) Comparison of the safety and immunogenicity of ΔaroCΔaroD and ΔcyaΔcrp Salmonella typhi strains in adult volunteers. Infect Immun 60: 536-41.
36. Nagai S., Yagihashi T., Ishihama A. (1998) Avian pathogenic Escherichia coli strain produces a hemolysin, the expression of which is dependent on cyclic AMP receptor protein gene function. Vet Microbiol 60: 227-38.
37. Donnenberg M.S., Kaper J.B. (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 59: 4310-7.
38. Simon R., Priefer U., Puhler A. (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Bio/Technology 1: 784-91.
39. Corbett W.T., Berkhoff H.A., Vinal A.C. (1987) Epidemiological study of the relationship between Congo red binding Escherichia coli and avian colisepticemia. Can J Vet Res 51: 312-5.
40. Everett M.J., Jin Y.F., Ricci V., Piddock L.J. (1996) Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40: 2380-6.
41. Reed L.J., Muench H. (1939) A simple method for estimating fifty percent endpoints. Am J Hyg 27: 493-7.
42. Hassan J.O., Curtis R. III. (1994) Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotype. Infect Immun 62: 5519-27.
43. Allan W.H. (1975) Advances in immunization against Newcastle disease. Veterinary Annual 15: 140-3.